SFX by Ex Libris Inc.

Title:	HIV gp120: double lock strategy foils host defences
Source:	Structure [0969-2126] Sattentau, Quentin yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hendrickson, Peter D. "Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody." Nature 393.6686 (1998): 648-59.
description	2.	Wiley, D C C. "Atomic structure of the ectodomain from HIV-1 gp41." Nature 387.6631 (1997): 426-430.
description	3.	Alconcel, S. "fda-approved poly(ethylene glycol)–protein conjugate drugs." Polymer Chemistry 2.7 (2011): 1442-1448.
description	4.	Monroe, Eric B. "Hydrogen/Deuterium Exchange Analysis of HIV-1 Capsid Assembly and Maturation." Structure 18.11 (2010): 1483-1491.
description	5.	Wyatt, R. "The antigenic structure of the HIV gp120 envelope glycoprotein." Nature 393.6686 (1998): 705-11.
description	6.	Fu, Yun-Xin X. "Molecular motions of human HIV-1 gp120 envelope glycoproteins." Journal of molecular modeling 14.9 (2008): 857-70.
description	7.	Chen, B. "Structure of an unliganded simian immunodeficiency virus gp120 core." Nature 433.7028 (2005): 834-841.
description	8.	Tan, K. "Atomic structure of a thermostable subdomain of HIV-1 gp41." Proceedings of the National Academy of Sciences of the United States of America 94.23 (1997): 12303-12308.
description	9.	Kim, P S S. "Core structure of gp41 from the HIV envelope glycoprotein." Cell 89.2 (1997): 263-273.
description	10.	Kowalski, M. "Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1." Science 237.4820 (1987): 1351-5.
description	11.	Wu, P. "Dimeric association and segmental variability in the structure of human CD4." Nature 387.6632: 527-530.
description	12.	Chan, D C C. "HIV entry and its inhibition." Cell 93.5 (1998): 681-4.
description	13.	Burkitt, W. "RNA-induced conformational changes in a viral coat protein studied by hydrogen/deuterium exchange mass spectrometry." PCCP. Physical chemistry chemical physics 12.41 (2010): 13468-13475.
description	14.	Han, Y. "Identification and functional characterization of regions that can be crosslinked to RNA in the helicase-like domain of BaMV replicase." Virology 389.1-2 (2009): 34-44.
description	15.	Smith, René A. "Following the path of the virus: the exploitation of host DNA repair mechanisms by retroviruses." ACS Chemical Biology 1.4 (2006): 217-26.
description	16.	BRANNONPEPPAS, L. "Nanoparticle and targeted systems for cancer therapy." Advanced Drug Delivery Reviews 56.11 (2004): 1649-1659.
description	17.	Nair, G. "HIV integrase inhibitors as therapeutic agents in AIDS." Reviews in medical virology 17.4 (2007): 277-95.
description	18.	Veronese, F. M. "Bioconjugation in pharmaceutical chemistry." Il farmaco 54.8 (1999): 497-516.
description	19.	Otsuka Hidenori, H. "PEGylated nanoparticles for biological and pharmaceutical applications." Advanced Drug Delivery Reviews 55.3 (2003): 403-419.
description	20.	Lee, S. "Drug Delivery Systems Employing 1,6-Elimination: Releasable Poly(ethylene glycol) Conjugates of Proteins." Bioconjugate chemistry 12.2 (2001): 163-169.